A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
Clinical trial NCT03240120 · UNKNOWN
Trial details
- NCT number
- NCT03240120
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-01
- Primary completion
- 2021-05-31
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.